Royalty Pharma plc (NASDAQ:RPRX) Q2 2024 Earnings Call Transcript August 8, 2024
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.1709 EPS, expectations were $0.95.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma Second Quarter Earnings Conference Call. I would like now to turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
George Grofik: Good morning,...
